Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Int J Mol Sci ; 18(8)2017 Aug 22.
Artículo en Inglés | MEDLINE | ID: mdl-28829356

RESUMEN

Isorhamnetin glycosides are representative compounds of Opuntia ficus-indica that possess different biological activities. There is slight information about the changes in bioaccessibility induced by the glycosylation pattern of flavonoids, particularly for isorhamnetin. In this study, the bioaccessibility and permeability of isorhamnetin glycosides extracted from O. ficus-indica were contrasted with an isorhamnetin standard. Also, the plasma stability of these isorhamnetin glycosides after intravenous administration in rats was evaluated. Recoveries of isorhamnetin after oral and gastric digestion were lower than that observed for its glycosides. After intestinal digestion, isorhamnetin glycosides recoveries were reduced to less than 81.0%. The apparent permeability coefficient from apical (AP) to basolateral (BL) direction (Papp(AP-BL)) of isorhamnetin was 2.6 to 4.6-fold higher than those obtained for its glycosides. Isorhamnetin diglycosides showed higher Papp(AP-BL) values than triglycosides. Sugar substituents affected the Papp(AP-BL) of the triglycosides. Isorhamnetin glycosides were better retained in the circulatory system than the aglycone. After intravenous dose of the isorhamnetin standard, the elimination half-life was 0.64 h but increased to 1.08 h when the O. ficus-indica extract was administered. These results suggest that isorhamnetin glycosides naturally found in O. ficus-indica could be a controlled delivery system to maintain a constant plasmatic concentration of this important flavonoid to exert its biological effects in vivo.


Asunto(s)
Glicósidos/farmacocinética , Mucosa Intestinal/metabolismo , Opuntia/química , Extractos Vegetales/farmacocinética , Quercetina/análogos & derivados , Animales , Disponibilidad Biológica , Cromatografía Líquida de Alta Presión , Glicósidos/química , Humanos , Estructura Molecular , Permeabilidad , Extractos Vegetales/química , Quercetina/química , Quercetina/farmacocinética , Ratas , Reproducibilidad de los Resultados
2.
Oxid Med Cell Longev ; 2017: 7682569, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-29201273

RESUMEN

Metabolic syndrome (MS) increases cardiovascular risk and is associated with cardiac dysfunction and arrhythmias, although the precise mechanisms are still under study. Chronic inflammation in MS has emerged as a possible cause of adverse cardiac events. Male Wistar rats fed with 30% sucrose in drinking water and standard chow for 25-27 weeks were compared to a control group. The MS group showed increased weight, visceral fat, blood pressure, and serum triglycerides. The most important increases in serum cytokines included IL-1ß (7-fold), TNF-α (84%), IL-6 (41%), and leptin (2-fold), the latter also showing increased gene expression in heart tissue (35-fold). Heart function ex vivo in MS group showed a decreased mechanical performance response to isoproterenol challenge (ISO). Importantly, MS hearts under ISO showed nearly twofold the incidence of ventricular fibrillation. Healthy rat cardiomyocytes exposed to MS group serum displayed impaired contractile function and Ca2+ handling during ISO treatment, showing slightly decreased cell shortening and Ca2+ transient amplitude (23%), slower cytosolic calcium removal (17%), and more frequent spontaneous Ca2+ release events (7.5-fold). As spontaneous Ca2+ releases provide a substrate for ventricular arrhythmias, our study highlights the possible role of serum proinflammatory mediators in the development of arrhythmic events during MS.


Asunto(s)
Arritmias Cardíacas/patología , Citocinas/metabolismo , Síndrome Metabólico/patología , Contracción Miocárdica/fisiología , Agonistas Adrenérgicos beta/farmacología , Animales , Arritmias Cardíacas/complicaciones , Células Cultivadas , Modelos Animales de Enfermedad , Ecocardiografía , Corazón/efectos de los fármacos , Corazón/fisiología , Interleucina-1beta/metabolismo , Isoproterenol/farmacología , Leptina/metabolismo , Masculino , Síndrome Metabólico/complicaciones , Síndrome Metabólico/metabolismo , Contracción Miocárdica/efectos de los fármacos , Miocardio/metabolismo , Miocitos Cardíacos/citología , Miocitos Cardíacos/efectos de los fármacos , Miocitos Cardíacos/metabolismo , Ratas , Ratas Wistar , Suero/química , Tomografía Computarizada por Rayos X , Factor de Necrosis Tumoral alfa/metabolismo , Fibrilación Ventricular/etiología , Imagen de Cuerpo Entero
3.
Food Funct ; 6(3): 805-15, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25588195

RESUMEN

A diet rich in polyphenols can ameliorate some metabolic alterations associated with obesity and type 2 diabetes. Opuntia ficus-indica (OFI) is a plant rich in isorhamnetin glycosides and is highly consumed in Mexico. The purpose of this research was to determine the metabolic effect of an OFI extract on a mouse model of diet-induced obesity and in isolated pancreatic islets. OFI extract was added to a high fat (HF) diet at a low (0.3%) or high (0.6%) dose and administered to C57BL/6 mice for 12 weeks. Mice fed the HF diet supplemented with the OFI extract gained less body weight and exhibited significantly lower circulating total cholesterol, LDL cholesterol and HDL cholesterol compared to those fed the HF diet alone. The HF-OFI diet fed mice presented lower glucose and insulin concentration than the HF diet fed mice. However, the HF-OFI diet fed mice tended to have higher insulin concentration than control mice. The OFI extract stimulated insulin secretion in vitro, associated with increased glucose transporter 2 (GLUT2) and peroxisome proliferator-activated receptor gamma (PPARγ) mRNA content. Furthermore, the OFI extract improved glucose tolerance, and additionally increased energy expenditure. These metabolic improvements were associated with reduced adipocyte size, increased hepatic IRS1 tyr-608 and S6 K thr-389 phosphorylation. OFI isorhamnetin glycosides also diminished the hepatic lipid content associated with reduced mRNA expression of the endoplasmic reticulum stress markers and lipogenic enzymes and increased mRNA expression of genes related to fatty acid oxidation. Overall, the OFI extract prevented the development of metabolic abnormalities associated with diet-induced obesity.


Asunto(s)
Fármacos Antiobesidad/uso terapéutico , Suplementos Dietéticos , Glicósidos/uso terapéutico , Obesidad/dietoterapia , Opuntia/química , Extractos Vegetales/uso terapéutico , Quercetina/análogos & derivados , Animales , Fármacos Antiobesidad/análisis , Fármacos Antiobesidad/química , Fármacos Antiobesidad/aislamiento & purificación , Dieta Alta en Grasa/efectos adversos , Metabolismo Energético , Regulación de la Expresión Génica , Transportador de Glucosa de Tipo 2/agonistas , Transportador de Glucosa de Tipo 2/genética , Transportador de Glucosa de Tipo 2/metabolismo , Glicósidos/administración & dosificación , Glicósidos/análisis , Glicósidos/aislamiento & purificación , Hiperglucemia/etiología , Hiperglucemia/prevención & control , Hiperlipidemias/etiología , Hiperlipidemias/prevención & control , Insulina/sangre , Insulina/metabolismo , Secreción de Insulina , Islotes Pancreáticos/metabolismo , Masculino , Ratones Endogámicos C57BL , Obesidad/etiología , Obesidad/metabolismo , Obesidad/fisiopatología , PPAR gamma/agonistas , PPAR gamma/genética , PPAR gamma/metabolismo , Extractos Vegetales/administración & dosificación , Extractos Vegetales/química , Extractos Vegetales/aislamiento & purificación , Tallos de la Planta/química , Quercetina/administración & dosificación , Quercetina/análisis , Quercetina/aislamiento & purificación , Quercetina/uso terapéutico , Distribución Aleatoria , Ratas Wistar , Técnicas de Cultivo de Tejidos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA